Will Ketek Manufacturer Escape Liability?
New York, NY: A recent decision by the United States District Court in the Eastern District of New York has ruled against class-action status in a lawsuit by plaintiffs against Sanofi-Aventis, the manufacturer of
Ketek. The latter is an antibiotic that was brought to market under questionable circumstances and was found to be harmful, with 53 reported cases of liver failure and four deaths by 2007—just three years after the drug was brought to market.
[READ MORE]
Judge Denies Sanofi-Aventis' Motion to Dismiss
St. Clair, IL: In a victory for plaintiffs, a judge in St. Clair County has denied a motion by Sanofi-Aventis to dismiss or transfer 59 claims against the company regarding its
antibiotic, Ketek. The judge found that Sanofi-Aventis did not show that St. Clair County was an inadequate forum for the cases and refused to dismiss claims from plaintiffs in other states
[READ MORE]
Ketek and the FDA: Medicinal Terrorism?
Washington, DC: There are those who feel that the real threat to the American people isn't terrorism: it's the seemingly endless supply of dangerous prescription drugs that carry approval by the US Food and Drug Administration (FDA).
Ketek is alleged to be one of them, after patients have
died or been
seriously harmed from the antibiotic
[READ MORE]